T lymphocytes, including CD8+ cytotoxic T lymphocytes (CTLs) and CD4+ Th1 cells, natural killer (NK) cells, and DCs are major players in tumor-associated immune responses [139]. The gene discussed is CD4; the disease is neoplasm.